Nordic Pharma is a privately owned, medium-size, marketing and sales Pharma company with a history of internal product development and acquisitions. We have established deep roots throughout Europe, and more recently, expanded outside of Europe, with increased partnerships worldwide.
We focus on the development and commercialization of specialty products, which include, but are not limited to, niche hospital and orphan products, to address unmet medical needs. Our expertise relies on the development and sales of our own products, but also on partner products acquired at various stages of development. Today, Nordic Pharma has a range of highly specialized proprietary and in-licensed products in the following therapeutic areas: Rheumatology, Ophthalmology, Women’s Health and Critical Care (Anaesthesia, Haematology, Oncology).
Our driving force is about innovative and efficient products to fight diseases. We strive to bring solutions to specific unmet medical needs, contributing to improved patient care.
